The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen(Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
More
The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen(Johnson & Johnson), for emergency use in all countries and for COVAX roll-out.
More